JPMorgan Chase & Co. (JPM) is a diversified bank holding company, not an ETF, so the central target is built from individual equity analyst price targets. The $380 figure is the arithmetic mean of 16 recent targets, rounded to a reader-friendly level. The most current targets reviewed range from about $350 (Citi, maintained in October 2026) to $425 (Barclays, maintained in early November 2026), with the group clustered mainly in the $360–$400 zone.
Views differ meaningfully even among bulls. Barclays ($425) and UBS ($400) sit at the optimistic end, while Citi ($350) and Truist ($361) reflect more measured expectations. Analysts cite a similar set of fundamentals but disagree on how much credit the shares should get for them. Notably, broader aggregators report slightly different averages — for example, an average near $373 across a wider poll of about two dozen analysts — because they include older or lower targets. The $380 central target used here reflects only the most current, individually attributable figures. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The shares closed near $334.49 in early November 2026. Reaching $380 would require a move of roughly 13.6%, a substantial but not extreme advance for a large-cap financial. The stock trades near 14 times trailing EPS (earnings per share), which is not demanding by historical standards for JPMorgan but reflects the market already rewarding the bank's consistent execution.
The path toward the target would most plausibly run through sustained earnings growth, a continued recovery in investment-banking and markets activity, and steady net interest income. Because JPMorgan is a diversified franchise spanning consumer banking, corporate and investment banking, and asset and wealth management, any one segment rarely determines the outcome — the target depends on broad-based execution rather than a single catalyst.
The bank's most recent quarterly report showed revenue rising roughly 8% year over year, with strength in investment-banking fees, equities trading, and asset-management fees, where client assets continued to grow. Management outlined a central-case net interest income framework for 2027 that signals confidence in a durable revenue base. The balance sheet remains solid, with a Common Equity Tier 1 (CET1) capital ratio near 13.9%, giving flexibility for buybacks and dividends.
A supportive rate environment, resilient consumer spending, and JPMorgan's scale advantage in capital markets are recurring themes in bullish analyst notes. Several firms raised targets through the second half of 2026, reflecting confidence in earnings power rather than a re-rating alone.
The clearest headwind is expenses, which have been growing faster than revenue in some quarters, pressuring operating leverage. Credit costs are normalizing from unusually low levels, and a deteriorating macroeconomic backdrop could accelerate that trend. Some analysts, such as Citi, hold a neutral stance precisely because they see the shares as already pricing in strong execution.
Valuation compression is another risk: if rate expectations shift or capital-markets activity slows, the multiple could contract even if earnings hold up. The shares have also shown sharp single-session swings, underscoring that sentiment toward financials can turn quickly.
The 52-week range runs from roughly $279 to about $366.50. The stock recently pulled back from an intraday high near $360 into the low $330s, leaving the $366–$367 area as a notable prior high and near-term resistance zone. On the downside, the $333–$334 area served as recent support, with the psychological $330 level just beneath it. Above the prior high, the next widely watched round-number zone is $400, which sits above the central target and helps frame the range of possibilities.
Analyst price targets generally reflect a roughly 12-month research horizon, though firms do not always state one explicitly and individual assumptions vary. Investors should watch quarterly earnings and net interest income guidance, expense trends, credit and net charge-off data, and capital-return decisions. Broader factors — Federal Reserve rate policy, the yield curve, and the pace of investment-banking and trading activity — will also influence whether the shares can build toward the target. From what I see, monitoring these elements closely helps put the price target in context.
The central $380 target for JPMorgan Chase represents the average of 16 current analyst price targets, implying roughly 13.6% upside from a close near $334.49. The bull case rests on resilient earnings, a dominant capital-markets position, and a strong balance sheet, while the bear case centers on rising expenses, credit normalization, and valuation that may already reflect much of the optimism. The wide $350-to-$425 range shows genuine disagreement about how far the shares can run. Whether JPM reaches $380 depends on execution, rates, and the broader economy — none of which can be predicted with certainty. Investors should watch earnings, guidance, expenses, and macro conditions rather than any single price level.
In my own research process, I find Tickeron’s AI Daily Buy/Sell Signals helpful for tracking how market conditions and technical factors evolve for holdings like JPM. The platform applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on changing data and AI-driven analysis. This complements fundamental work by offering a systematic way to stay updated on potential shifts without relying solely on manual review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JPM saw its Momentum Indicator move above the 0 level on November 02, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 82 similar instances where the indicator turned positive. In 52 of the 82 cases, the stock moved higher in the following days. The odds of a move higher are at 63%.
The Moving Average Convergence Divergence (MACD) for JPM just turned positive on October 12, 2026. Looking at past instances where JPM's MACD turned positive, the stock continued to rise in 27 of 47 cases over the following month. The odds of a continued upward trend are 57%.
Following a +2.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where JPM advanced for three days, in 217 of 364 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 183 of 342 cases where JPM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 57 cases where JPM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 51%.
JPM moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JPM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
JPM broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 21, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. JPM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: JPM's P/B Ratio (2.515) is slightly higher than the industry average of (1.500). P/E Ratio (14.307) is within average values for comparable stocks, (11.703). Projected Growth (PEG Ratio) (1.562) is also within normal values, averaging (2.139). Dividend Yield (0.020) settles around the average of (0.035) among similar stocks. P/S Ratio (4.888) is also within normal values, averaging (3.867).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks